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Abstract
Precision medicine is of considerable interest in clinical, academic and regulatory
parties. The key to precision medicine is the optimal treatment regime. Recently,
Zhou et al. (2017) developed residual weighted learning (RWL) to construct the opti-
mal regime that directly optimize the clinical outcome. However, this method involves
computationally intensive non-convex optimization, which cannot guarantee a global
solution. Furthermore, this method does not possess fully semiparametrical efficiency.
In this article, we propose augmented outcome-weighted learning (AOL). The method is
built on a doubly robust augmented inverse probability weighted estimator (AIPWE),
and hence constructs semiparametrically efficient regimes. Our proposed AOL is closely
related to RWL. The weights are obtained from counterfactual residuals, where nega-
tive residuals are reflected to positive and accordingly their treatment assignments are
switched to opposites. Convex loss functions are thus applied to guarantee a global
solution and to reduce computations. We show that AOL is universally consistent,
i.e., the estimated regime of AOL converges the Bayes regime when the sample size
approaches infinity, without knowing any specifics of the distribution of the data. We
also propose variable selection methods for linear and nonlinear regimes, respectively,
to further improve performance. The performance of the proposed AOL methods is
illustrated in simulation studies and in an analysis of the Nefazodone-CBASP clinical
trial data.
Keywords: Optimal Treatment Regime; RKHS; Universal consistency; Residuals; Double
robustness.
1 Introduction
Most medical treatments are designed for the “average patient”. Such a “one-size-fits-all”
approach is successful for some patients but not always for others. Precision medicine,
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also known as personalized medicine, is an innovative approach to disease prevention and
treatment that take into account individual variability in clinical information, genes, envi-
ronments and lifestyles. Currently, precision medicine is of considerable interest in clinical,
academic, and regulatory parties. There are already several FDA-approved treatments that
are tailored to specific characteristics of individuals. For example, ceritinib, a recently FDA
approved drug for the treatment of lung cancer, is highly active in patients with advanced,
ALK-rearranged non-small-cell lung cancer (Shaw et al. 2014).
The key to precision medicine is the optimal treatment regime. LetX = (X1, · · · ,Xp)T ∈
X be a patient’s clinical covariates, A ∈ A = {+1,−1} be the treatment assignment, and R
be the observed clinical outcome. Assume without loss of generality that larger values of R
are more desirable. A treatment regime d is a function from X to A. An optimal treatment
regime is a regime that maximizes the outcome under this regime. Assuming that the data
generating mechanism is known, the optimal treatment regime is related to the contrast
δ(x) = µ+1(x)− µ−1(x),
where µ+1(x) = E(R|X = x, A = +1) and µ−1(x) = E(R|X = x, A = −1). The Bayes
optimal regime is d∗(x) = 1 if δ(x) > 0 and −1 otherwise.
Most of published optimal treatment strategies estimate the contrast δ(x) by modelling
either the conditional mean outcomes or contrast directly based on data from randomized
clinical trials or observational studies (see Moodie et al. (2014); Murphy (2003); Robins
(2004); Taylor et al. (2015) and references therein). They obtain treatment regimes in-
directly by inverting the regression estimates. They are regression-based approaches for
treatment regimes. For instance, Qian and Murphy (2011) proposed a two-step procedure
that first estimates a conditional mean for the outcome and then determines the treatment
regime by comparing conditional mean outcomes across various treatments. The success
of these regression-based approaches depends on the correct specification of models and
on the high precision of the model estimates. However, in practice, the heterogeneity in
population makes the regression model estimate complicated.
Alternatively, Zhao et al. (2012) proposed a classification-based approach, called out-
come weighted learning (OWL), to utilize the weighted support vector machines (Vapnik
1995) to estimate the optimal treatment regime directly. Zhang et al. (2012a) also proposed
a general framework to make use of classification methods to the optimal treatment regime
problem.
Indeed, the classification-based approaches follow Vapnik’s main principle (Vapnik 1995):
“When solving a given problem, try to avoid solving a more general problem as an interme-
diate step.” As in Figure 1, the aim of optimal treatment regimes is to estimate the form of
the decision boundary δ(x) = 0. Regression-based approaches find the decision boundary
by solving a general problem that estimates δ(x) for any x ∈ X . For the optimal treatment
regime, it is sufficient to find an accurate estimate of δ(x) only near the zeros of δ(x). In
general, finding the optimal regime is an easier problem than regression function estima-
tion. Classification-based approaches, which seek the decision boundary directly, provide a
flexible framework from a different perspective.
Recently, Zhou et al. (2017) proposed residual weighted learning (RWL), which uses the
residual from a regression fit of outcome as the pseudo-outcome, to improve finite sample
performance of OWL. However, this method, involving a non-convex loss function, presents
numerous challenges in computations, which hinders its practical use. For non-convex op-
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Figure 1: Example of contour of δ(x) on x = (x1, x2)
T . The decision boundary is δ(x) = 0.
The optimal treatment is 1 if δ(x) > 0, and −1 otherwise. The decision boundary can be
approximated by a linear function, although the contrast function δ(x) is not linear on x.
timization, a global solution is not guaranteed, and the computation is generally intensive.
Athey and Wager (2017) also pointed out that RWL does not possess fully semiparamet-
rical efficiency. In this article, we propose augmented outcome-weighted learning (AOL).
The method is built on a doubly robust augmented inverse probability weighted estimator
(AIPWE), and hence constructs semiparametrically efficient regimes. Although this arti-
cle focuses on randomized clinical trials, the double robustness is particularly useful for
observational studies. Our proposed AOL is closely related to RWL. The weights are ob-
tained from counterfactual residuals, where negative residuals are reflected to positive and
accordingly their treatment assignments are switched to opposites. Convex loss functions
are thus applied to reduce computations. AOL inherits almost all desirable properties of
RWL. Similar with RWL, AOL is also universally consistent, i.e., the estimated regime of
AOL converges the Bayes regime when the sample size approaches infinity, without know-
ing any specifics of the distribution of the data. The finite sample performance of AOL is
demonstrated in numerical simulations.
The remainder of the article is organized as follows. In Section 2.1, we review outcome
weighted learning and residual weighted learning. In Section 2.2 and 2.3, we propose
augmented outcome-weighted learning. We discover the connection between augmented
outcome-weighted learning and residual weighted learning in Section 2.4. We establish
universal consistency for the proposed AOL in Section 2.5. The variable selection techniques
for AOL are discussed in Section 2.6. We present simulation studies to evaluate finite sample
performance of the proposed methods in Section 3. The method is then illustrated on the
Nefazodone-CBASP clinical trial in Section 4. We conclude the article with a discussion in
Section 5. All the technical proofs are provided in Appendix.
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2 Method
2.1 Review of outcome weighted learning and residual weighted learning
In this article, random variables are denoted by uppercase letters, while their realizations
are denoted by lowercase letters. Consider a two-arm randomized trial. Let π(a,x) :=
P (A = a|X = x) be the probability of being assigned treatment a for patients with clinical
covariates x. It is predefined in the trial design. We assume π(a,x) > 0 for all a ∈ A and
x ∈ X .
We use the potential outcomes framework (Rubin 1974) to precisely define the optimal
treatment regime. Let R∗(+1) and R∗(−1) denote the potential outcomes that would be
observed had a subject received treatment +1 or −1. There are two assumptions in the
framework. The actually observed outcomes and potential outcomes are connected by the
consistency assumption, i.e., R = R∗(A). We further assume that conditional on covariates
X, the potential outcomes {(R∗(+1), R∗(−1)} are independent of A, the treatment that
has been actually received. This is the assumption of no unmeasured confounders (NUC).
This assumption is automatically hold in a randomized clinical trial.
For an arbitrary treatment regime d, we can thus define its potential outcomeR∗(d(X)) =
R∗(+1)I(d(X) = +1)+R∗(−1)I(d(X) = −1), where I(·) is the indicator function. It would
be the observed outcome if a subject from the population were to be assigned treatment ac-
cording to regime d. The expected potential outcome under any regime d, defined as V(d) =
E(R∗(d)), is called the value function associated with regime d. Thus, an optimal regime d∗
is a regime that maximizes V(d). Letm(x, d) = µ+1(x)I(d(x) = +1)+µ−1(x)I(d(x) = −1).
Under the consistency and NUC assumptions, it is straightforward to show that
V(d) = E
(
m(X, d))
)
= E
(
R
π(A,X)
I
(
A = d(X)
))
. (1)
Thus finding d∗ is equivalent to the following minimization problem:
d∗ ∈ argmin
d
E
(
R
π(A,X)
I
(
A 6= d(X)
))
. (2)
Zhao et al. (2012) viewed this as a weighted classification problem, and proposed outcome
weighted learning (OWL) to apply statistical learning techniques to optimal treatment
regimes. However, as discussed in Zhou et al. (2017), this method is not perfect. Firstly,
the estimated regime of OWL is affected by a simple shift of the outcome R. Hence es-
timates from OWL are unstable especially when the sample size is small. Secondly, since
OWL needs the outcome to be nonnegative to gain computational efficiency from convex
programming, OWL works similarly as weighted classification to reduce the difference be-
tween the estimated and true treatment assignments. Thus the regime by OWL tends
to retain the treatments that subjects actually received. This behavior is not ideal for
data from a randomized clinical trial, since treatments are actually randomly assigned to
patients.
To alleviate these problems, Zhou et al. (2017) proposed residual weighted learning
(RWL), in which the misclassification errors are weighted by residuals of the outcome R
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from a regression fit on clinical covariates X. The residuals are calculated as
Rg = R− g(X).
Zhou et al. (2017) used g1(X) = E(
R
2π(A,X) |X) as a choice of g(X). Unlike OWL in (2),
RWL targets the following optimization problem,
d∗ ∈ argmin
d
E
(
Rg
π(A,X)
I
(
A 6= d(X)
))
.
Suppose that the realization data {(xi, ai, ri) : i = 1, · · · , n} are collected independently.
For any decision function f(x), let df (x) = sign
(
f(x)
)
be the associated regime. RWL aims
to minimize the following regularized empirical risk,
1
n
n∑
i=1
rg,i
π(ai,xi)
T
(
aif(xi)
)
+ λ||f ||2, (3)
where rg,i = ri − g(xi), T (·) is a continuous surrogate loss function, ||f || is some norm for
f , and λ is a tuning parameter.
Since some residuals are negative, convex surrogate loss functions are not appropriate
in (3). Zhou et al. (2017) considered a non-convex loss, the smoothed ramp loss function.
However, the non-convexity presents significant challenges for solving the optimization prob-
lem (3). Unlike convex functions, non-convex functions may possess local optima that are
not global optima, and most of efficient optimization algorithms, such as gradient descent
and coordinate descent, are only guaranteed to converge to a local optimum. The theoretical
properties of RWL establish on the global optimum. Although Zhou et al. (2017) applied
a difference of convex (d.c.) algorithm to address the non-convex optimization problem by
solving a sequence of convex subproblems to increase the likelihood of reaching a global
minimum, the global optimization is not guaranteed (Sriperumbudur and Lanckriet 2009).
The d.c. algorithm is still computationally intensive. In addition, RWL may connect with
AIPWE as discussed in Zhou et al. (2017), but it does not have fully semiparametrical
efficiency (Athey and Wager 2017).
2.2 Augmented outcome-weighted learning (AOL)
Let us come back to equation (1). The first equality is the foundation of regression-
based approaches, while the second inspired outcome weighted learning (Zhao et al. 2012).
Zhang et al. (2012a) combined these two perspectives through a doubly robust augmented
inverse probability weighted estimator (Bang and Robins 2005, AIPWE) of the value func-
tion.
Recall that µ+1(x) = E(R|X = x, A = +1), µ−1(x) = E(R|X = x, A = −1), and
m(x, d) = µ+1(x)I(d(x) = +1) + µ−1(x)I(d(x) = −1). Following Zhang et al. (2012b), we
start from the doubly robust AIPWE:
AIPWE(d) =
1
n
n∑
i=1
(
ri − mˆ(xi, d)
π(ai,xi)
I
(
ai = d(xi)
)
+ mˆ(xi, d)
)
,
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where mˆ(x, d) is an estimator of m(x, d), which is an estimator of
V(d) = E
(
R−m(X, d)
π(A,X)
I(A = d(X)) +m(X, d)
)
.
For an observational study, we are also required to estimate π(a,x) by the data. AIPWE(d)
is a consistent estimator of V(d) if either πˆ(a,x) or mˆ(x, d) is correctly specified. This is
the so-called double robustness. In a randomized clinical trial π(a,x) is known, hence even
if mˆ(x, d) is inconsistent, AIPWE(d) is still consistent.
Noting that
R−m(X, d)
π(A,X)
I
(
A = d(X)
)
+m(X, d) =
R− g˜(X)
π(A,X)
I
(
A = d(X)
)
+ µ−A(X),
where
g˜(x) := π(−1,x)µ+1(x) + π(+1,x)µ−1(x), (4)
maximizing AIPWE(d) is asymptotic to the following minimization problem
argmin
d
E
(
R− g˜(X)
π(A,X)
I
(
A 6= d(X))) . (5)
Let R˜ = R− g˜(X). As explained later in Section 2.4, R˜ is a form of residuals. At this
point, we may apply a similar non-convex surrogate loss in the regularization framework as
RWL in (3). However, it still suffers from local optimization and intensive computation.
To seek the optimal regime, we apply a finding in Liu et al. (2016) to take advantage
of efficient convex optimization. Note that
E
(
|R˜|
π(A,X)
I
(
A · sign(R˜) 6= d(X)
))
= E
(
R˜
π(A,X)
I
(
A 6= d(X)
))
+ E
(
R˜−
π(A,X)
)
,
where R˜− = max(−R˜, 0). Therefore finding d∗ in (5) is equivalent to the following opti-
mization problem,
d∗ ∈ argmin
d
E
(
|R˜|
π(A,X)
I
(
A · sign(R˜) 6= d(X)
))
,
where negative weights are reflected to positive, and accordingly their treatment assign-
ments are switched to opposites.
Similar with OWL and RWL, we seek the decision function f by minimizing a regularized
surrogate risk,
1
n
n∑
i=1
|r˜i|
π(ai,xi)
φ
(
ai · sign(r˜i)f(xi)
)
+
λ
2
||f ||2, (6)
where φ(·) is a continuous surrogate loss function, ||f || is some norm for f , and λ is a tuning
parameter controlling the trade-off between the empirical risk and the complexity of the
decision function f . This method is called augmented outcome-weighted learning (AOL)
in this article, since the weights are derived from augmented outcomes.
As the weights |r˜i|π(ai,xi) are all nonnegative, convex surrogate can be employed for efficient
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computation. In this article, we apply the Huberized hinge loss function (Wang et al. 2008),
φ(u) =


0 if u ≥ 1,
1
4(1− u)2 if − 1 ≤ u < 1,
−u if u < −1.
(7)
Other convex loss functions, such as the hinge loss, can be also applied in AOL. Although
the Huberized hinge loss has a similar shape with the hinge loss, the Huberized hinge loss
is smooth everywhere. Hence it has computational advantages in optimization.
2.3 Implementation of AOL
We derive an algorithm for the linear AOL in Section 2.3.1, and then generalize it to the
case of nonlinear learning through kernel mapping in Section 2.3.2. Both algorithms solve
convex optimization problems, and global solutions are guaranteed.
2.3.1 Linear Decision Rule for AOL
Consider a linear decision function f(x) = wTx+ b. The associated regime df will assign
a subject with clinical covariates x into treatment 1 if wTx+ b > 0 and −1 otherwise. In
(6), we define ||f || as the Euclidean norm of w. Then the minimization problem (6) can be
rewritten as
min
w,b
1
n
n∑
i=1
|r˜i|
π(ai,xi)
φ
(
ai · sign(r˜i)
(
wTxi + b
))
+
λ
2
wTw. (8)
There are many efficient numerical methods for solving this smooth unconstrained convex
optimization problem. One example is the limited-memory Broyden-Fletcher-Goldfarb-
Shanno (L-BFGS) algorithm (Nocedal 1980), a quasi-Newton method that approximates the
Broyden-Fletcher-Goldfarb-Shanno (BFGS) algorithm using a limited amount of computer
memory. When we obtain the solution (wˆ, bˆ), the decision function is fˆ(x) = wˆTx+ bˆ.
2.3.2 Nonlinear Decision rule for AOL
The nonlinear decision function f(x) can be represented by h(x) + b with h(x) ∈ HK and
b ∈ R, where HK is a reproducing kernel Hilbert space (RKHS) associated with a Mercer
kernel function K. The kernel function K(·, ·) is a positive definite function mapping from
X ×X to R. The norm in HK , denoted by || · ||K , is induced by the following inner product,
< f, g >K=
n∑
i=1
m∑
j=1
αiβjK(xi,xj),
for f(·) = ∑ni=1 αiK(·,xi) and g(·) = ∑mj=1 βjK(·,xj). The most widely used nonlinear
kernel in practice is the Gaussian Radial Basis Function (RBF) kernel, that is,
Kσ(x,z) = exp
(
− σ2||x− z||2
)
,
where σ > 0 is a free parameter whose inverse 1/σ is called the width of Kσ.
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Then minimizing (6) can be rewritten as
min
h,b
1
n
n∑
i=1
|r˜g,i|
π(ai,xi)
φ
(
ai · sign(r˜i)
(
h(xi) + b
))
+
λ
2
||h||2K . (9)
Due to the representer theorem (Kimeldorf and Wahba 1971), the nonlinear problem can
be reduced to finding finite-dimensional coefficients vi, and h(x) can be represented as∑n
j=1 vjK(x,xj). So the problem (9) is changed to
min
v,b
1
n
n∑
i=1
|r˜i|
π(ai,xi)
φ
(
ai · sign(r˜i)
( n∑
j=1
vjK(xi,xj) + b
))
+
λ
2
n∑
i,j=1
vivjK(xi,xj). (10)
Again, it is a smooth unconstrained convex optimization problem. We apply L-BFGS
algorithm to solve (10). When we obtain the solution (vˆ, bˆ), the decision function is fˆ(x) =∑n
j=1 vˆjK(x,xj) + bˆ.
2.4 Connection to residual weighted learning
Note that g˜(x) in (4) is a weighted average of µ+1(x) and µ−1(x). Hence R˜ = R − g˜(X)
is a form of residuals. The use of residuals in optimal treatment regimes is justified in
Zhou et al. (2017) as follows, for any measurable function g,
E
(
R− g(X)
π(A,X)
I
(
A 6= d(X)
))
= E
(
R
π(A,X)
− g(X)
)
− V(d).
For residual weighted learning in Zhou et al. (2017), the corresponding g(·) is
g1(x) = E
(
R
2π(A,X)
∣∣X = x) = 1
2
µ+1(x) +
1
2
µ−1(x). (11)
Similarly, Liu et al. (2016) applied unweighted regression to calculate residuals, where the
corresponding g(·) is
g2(x) = E (R|X = x) = π(+1,x)µ+1(x) + π(−1,x)µ−1(x). (12)
It is interesting to understand the implication of g˜(x) in (4). Under the consistency and
NUC assumptions, we can check that
E(R∗(−A)|X = x) = π(−1,x)µ+1(x) + π(+1,x)µ−1(x) = g˜(x).
g˜(x) is the expected outcome for subjects with covariate x had they received the opposite
treatments to the ones that they have actually received. g˜(x) is counterfactual, and cannot
be observed. It can be estimated by ˆ˜g(x) = π(−1,x)µˆ+1(x) + π(+1,x)µˆ−1(x), where
µˆ+1(x) and µˆ−1(x) are estimates of µ+1(x) and µ−1(x), respectively. Noting that
g˜(x) = E
(
π(−A,X)
π(A,X)
R
∣∣X = x) = π(−1,x)µ+1(x) + π(+1,x)µ−1(x), (13)
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g˜(x) also can be estimated by weighted regression directly, where weights are π(−A,x)π(A,x) .
In a randomized clinical trial with usual equal allocation ratio 1:1, g1(x), g2(x) and g˜(x)
coincide. If the allocation ratio is unequal, they are different. Compared with the regression
weights of g1(x) in (11) and of g2(x) in (12), g˜(x) in (13) utilizes a more extreme set of
weights. For example, in a randomized clinical trial with the allocation ratio 3 : 1, i.e., the
number of subjects in arm +1 is three times as that in arm −1, the weights in (12) for two
arms are both 1 (unweighted), the weights in (11) are 2/3 and 2, and the weights in (13)
are 1/3 and 3.
Our proposed AOL is closely related to RWL, as we just discussed that AOL uses
counterfactual residuals. AOL possesses almost all desirable properties of RWL. First,
by using residuals, AOL stabilizes the variability introduced from the original outcome.
Second, to minimize the empirical risk in (6), for subjects with positive residuals, AOL
tends to recommend the same treatment assignments that subjects have actually received;
for subjects with negative residuals, AOL is apt to give the opposite treatment assignments
to what they have received. Third, AOL is location-scale invariant with respect to the
original outcomes. Specifically, the estimated regime from AOL is invariant to a shift of
the outcome; it is invariant to a scaling of the outcome with a positive number; the regime
from AOL that maximizes the outcome is opposite to the one that minimizes the outcome.
These are intuitively sensible. The only nice property of RWL that is not inherited by AOL
is the robustness to outliers because of the unbounded convex loss in AOL. However, we
may apply an appropriate method or model estimating residuals to reduce the probability
of outliers.
2.5 Theoretical properties
In this section, we establish theoretical properties for AOL. Recall that for any treatment
regime d : X → A, the value function is defined as
V(d) = E
(
R
π(A,X)
I
(
A = d(X)
))
.
Similarly, we define the risk function of a treatment regime d as
R(d) = E
(
R
π(A,X)
I
(
A 6= d(X)
))
.
The regime that minimizes the risk is the Bayes regime d∗ = argmindR(d), and the corre-
sponding risk R∗ = R(d∗) is the Bayes risk. Recall that the Bayes regime is d∗(x) = 1 if
δ(x) > 0 and −1 otherwise.
Let φ : R 7→ R+, where R+ = [0,+∞), be a convex function. In this section, we
investigate a general result, and do not limit φ as the Huberized hinge loss. A few popular
convex surrogate examples are listed as follows:
• Hinge loss: φ(u) = (1− u)+, where (v)+ = max(0, v),
• Squared hinge loss: φ(u) = [(1 − u)+]2,
• Least squares loss: φ(u) = (1− u)2,
• Huberized hinge loss as shown in (7),
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• Logistic loss: φ(u) = log(1 + exp(−u)),
• Distance weighted discrimination (DWD) loss:
φ(u) =
{
1
u if u ≥ 1,
2− u if u < 1,
• Exponential loss: φ(u) = exp(−u).
The hinge loss and squared hinge loss are widely used in support vector machines (Vapnik
1995). The least squares loss is applied to regularization networks (Evgeniou et al. 2000).
The loss function in the logistic regression is just the logistic loss. The DWD loss is the
loss function in the distance-weighted discrimination (Marron et al. 2007). The exponential
loss is used in AdaBoost (Freund and Schapire 1997).
For any measurable function g : X 7→ R, recall that Rg = R − g(x). In this section,
we do not require g to be a regression fit of R, and g can be any arbitrary function. For a
decision function f : X 7→ R, we proceed to define a surrogate φ-risk function:
Rφ,g(f) = E
( |Rg|
π(A,X)
φ
(
A · sign(Rg)f(X)
))
. (14)
Similarly, the minimal φ-risk as R∗φ,g = inff Rφ,g(f) and f∗φ,g = argminf Rφ,g(f).
The performance of the associated regime df = sign(f) is measured by the excess risk
∆R(f) = R(df )−R∗. Similarly, we define the excess φ-risk as ∆Rφ,g(f) = Rφ,g(f)−R∗φ,g.
Suppose that a sample Dn = {Xi, Ai, Ri}ni=1 is independently drawn from a probability
measure P on X × A × R, where X ⊂ Rp is compact. Let fDn,λn ∈ HK + {1}, i.e.
fDn,λn = hDn,λn + bDn,λn , where hDn,λn ∈ HK and bDn,λn ∈ R, be a global minimizer of the
following optimization problem:
min
f=h+b∈HK+{1}
1
n
n∑
i=1
|Rg,i|
π(Ai,Xi)
φ
(
Ai · sign(Rg,i)f(Xi)
)
+
λn
2
||h||2K , (15)
where Rg,i = Ri − g(Xi). Here we suppress φ and g from the notations of fDn,λn , hDn,λn
and bDn,λn .
The purpose of the theoretical analysis is to investigate universal consistency of the
associated regime of fDn,λn . The concept of universal consistency is given in Zhou et al.
(2017). A universally consistent regime method eventually learns the Bayes regime without
knowing any specifics of the distribution of the data when the sample size approaches
infinity. Mathematically, a regime d is universally consistent when limn→∞R(d) = R∗ in
probability.
2.5.1 Fisher consistency
The first question is whether the loss function used is Fisher consistent. The concept of
Fisher consistency is brought from pattern classification (Lin 2002). For optimal treatment
regimes, a loss function is Fisher consistent if the loss function alone can be used to identify
the Bayes regime when the sample size approaches infinity, i.e., R(sign(f∗φ,g)) = R(d∗). We
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define
η1(x) = E(R
+
g |X = x, A = +1) + E(R−g |X = x, A = −1),
η2(x) = E(R
+
g |X = x, A = −1) + E(R−g |X = x, A = +1), (16)
where R+g = max(Rg, 0) and R
−
g = max(−Rg, 0). We suppress the dependence on g from
the notations. Note that
η1(x)− η2(x) = E(R|X = x, A = +1)− E(R|X = x, A = −1) = µ+1(x)− µ−1(x).
The sign of η1(x) − η2(x) is just the Bayes regime on x. After some simple algebras, the
φ-risk in (14) can be shown as
Rφ,g(f) = E
(
η1(X)φ
(
f(X)
)
+ η2(X)φ
( − f(X))).
Now we introduce the generic conditional φ-risk,
Qη1,η2(α) = η1φ(α) + η2φ(−α),
where η1, η2 ∈ R+ and α ∈ R. The notation suppresses the dependence on φ and g. We
define the optimal conditional φ-risk,
H(η1, η2) = Qη1,η2(α
∗) = min
α∈R
Qη1,η2(α),
and furthermore define,
H−(η1, η2) = min
α:α(η1−η2)≤0
Qη1,η2(α).
H−(η1, η2) is the optimal value of the conditional φ-risk, under the constraint that the sign
of the argument α disagrees with the Bayes regime. Fisher consistency is equivalent to
H−(η1, η2) > H(η1, η2) for any η1, η2 ∈ [0,∞) with η1 6= η2. The condition is similar with
that of classification calibration in Bartlett et al. (2006). When φ is convex, this condition
is equivalent to a simpler condition on the derivative of φ at 0.
Theorem 2.1. Assume that φ is convex. Then φ is Fisher consistent if and only if φ′(0)
exists and φ′(0) < 0.
It is interesting to note that the necessary and sufficient condition for a convex surrogate
loss function φ to yield a Fisher consistent regime concerns only its local property at 0. All
surrogate loss function listed above are Fisher consistent.
2.5.2 Relating excess risk to excess φ-risk
We now turn to the excess risk and show how it can be bounded through the excess φ-risk.
It is easy to verify that the excess φ-risk can be expressed as
∆Rφ,g(f) = E
(
Qη1(X),η2(X)(f(X))−minα∈RQη1(X),η2(X)(α)
)
.
Let ∆Qη1,η2(f) = Qη1,η2(f)−minα∈RQη1,η2(α) = Qη1,η2(f)−Hη1,η2 .
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Theorem 2.2. Assume φ is convex, φ′(0) exists and φ′(0) < 0. In addition, suppose that
there exist constants C > 0 and s ≥ 1 such that
|η1 − η2|s ≤ Cs∆Qη1,η2(0),
Then
∆R(f) ≤ C (∆Rφ,g(f))1/s .
As shown in the examples below, ∆Qη1,η2(0) is often related to η1 + η2. The following
theorem handles this situation.
Theorem 2.3. Assume φ is convex, φ′(0) exists, and φ′(0) < 0. Suppose E
(
|Rg|
π(A,X)
)
≤Mg.
In addition, suppose that there exist a constant s ≥ 2 and a concave increasing function
h : R+ → R+ such that
|η1 − η2|s ≤ h(η1 + η2)∆Qη1,η2(0),
Then
∆R(f) ≤ (h(Mg))1/s (∆Rφ,g(f))1/s .
We now examine the consequences of these theorems on the examples of loss functions.
Here we only present results briefly, and show details in Appendix A. Except for Examples
1 and 6, we assume that E
(
|Rg|
π(A,X)
)
is bounded by Mg in all other examples.
Example 1 (hinge loss). As shown in Appendix A,Hη1,η2 = 2min(η1, η2), and ∆Qη1,η2(0) =
|η1 − η2|. By Theorem 2.2, ∆R(f) ≤ ∆Rφ,g(f).
Example 2 (squared hinge loss). Consider the loss function φ(α) = [(1 − α)+]2. We
have (η1 − η2)2 = (η1 + η2)∆Qη1,η2(0). By Theorem 2.3, ∆R(f) ≤
√
Mg(∆Rφ,g(f))1/2.
Example 3 (least squares loss). Now consider the loss function φ(α) = (1 − α)2. Both
Hη1,η2 and ∆Qη1,η2(0) are the same as those in the previous example. Hence the bound in
the previous example also applies to the least squares loss.
Example 4 (Huberized hinge loss). We can simply obtain that (η1 − η2)2 = 4(η1 +
η2)∆Qη1,η2(0). By Theorem 2.3,
∆R(f) ≤ 2√Mg(∆Rφ,g(f))1/2. (17)
Example 5 (logistic loss). We consider the loss function φ(α) = log(1+ exp(−α)). This
is a little complicated case. As shown in Appendix A, (η1 − η2)2 ≤ 8(η1 + η2)∆Qη1,η2(0).
Then by Theorem 2.3, we have ∆R(f) ≤√8Mg(∆Rφ,g(f))1/2.
Example 6 (DWD loss). As shown in Appendix A, we obtain ∆Qη1,η2(0) ≥ |η1 − η2|.
Then by Theorem 2.2, ∆R(f) ≤ ∆Rφ,g(f).
Example 7 (exponential loss). Consider the loss function φ(α) = exp(−α). We have
Hη1,η2 = 2
√
η1η2, and ∆Qη1,η2(0) = (
√
η1−√η2)2. Then (η1− η2)2 ≤ 2(η1+ η2)∆Qη1,η2(0).
By Theorem 2.3, ∆R(f) ≤√2Mg(∆Rφ,g(f))1/2.
2.5.3 Universal consistency
We will establish universal consistency of the regime dfDn,λn = sign(fDn,λn). The following
theorem shows the convergence of φ-risk on the sample dependent function fDn,λn . We
apply empirical process techniques to show consistency.
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Theorem 2.4. Suppose φ is a Lipschitz continuous function. Assume that we choose a
sequence λn > 0 such that λn → 0 and nλn → ∞. For any distribution P for (X, A,R)
satisfying
|Rg|
π(A,X) ≤Mg <∞ and |
√
λnbDn,λn | ≤Mb <∞ almost everywhere, we have that
in probability,
lim
n→∞
Rφ,g(fDn,λn) = inf
f∈HK+{1}
Rφ,g(f).
When the loss function φ satisfies Theorem 2.2 or 2.3, starting from Theorem 2.4,
universally consistent follows if inff∈HK+{1}Rφ,g(f) = R∗φ,g. This condition requires the
concept of universal kernels (Steinwart and Christmann 2008). A continuous kernel K on
a compact metric space X is called universal if its associated RKHS HK is dense in C(X ),
the space of all continuous functions f : X → R on the compact metric space X endowed
with the usual supremum norm. The next Lemma shows that the RKHS HK of a universal
kernel K is rich enough to approximate arbitrary decision functions.
Lemma 2.5. Let K be a universal kernel, and HK be the associated RKHS. Suppose that
φ is a Lipschitz continuous function, and f∗φ,g is measurable and bounded, |f∗φ,g| ≤ Mf .
For any distribution P for (X, A,R) satisfying
|Rg|
π(A,X) ≤ Mg <∞ almost everywhere with
regular marginal distribution on X, we have
inf
f∈HK+{1}
Rφ,g(f) = R∗φ,g.
Our proposed AOL uses the Huberized hinge loss. Combining all the theoretical re-
sults and the excess risk bound in (17) together, the following proposition shows universal
consistency of AOL with the Huberized hinge loss.
Proposition 2.6. Let K be a universal kernel, and HK be the associated RKHS. Let φ
be the Huberized hinge loss function. Assume that we choose a sequence λn > 0 such that
λn → 0 and nλn →∞. For any distribution P for (X, A,R) satisfying |Rg|π(A,X) ≤Mg <∞
almost everywhere with regular marginal distribution on X, we have that in probability,
lim
n→∞
R(sign(fDn,λn)) = R∗.
In the proof of Proposition 2.7, we provide a bound on bDn,λn . The similar trick can be
applied to hinge loss, squared hinge loss, and least squares loss. Thus for these three loss
functions, it is not hard to derive their universal consistency. The exponential loss function
is not Lipschitz continuous, so the learning regime with this loss is probably not universally
consistent.
For the logistic loss and DWD loss, they do not satisfy Lemma 2.5 since f∗φ,g is not
bounded. We require stronger conditions for consistency. Firstly, we may assume that
both η1(x) and η2(x) in (16) are continuous. This assumption is plausible in practice.
Secondly, we still need an assumption on bounded bDn,λn as in Theorem 2.4 to exclude
some trivial situations, for example, where A · sign(Rg) = 1 almost everywhere. We present
the result in the following proposition. The proof is simple and we omit it.
Proposition 2.7. Let K be a universal kernel, and HK be the associated RKHS. Let φ
be the logistic loss or the DWD loss. Assume that we choose a sequence λn > 0 such that
λn → 0 and nλn → ∞. For any distribution P for (X, A,R) satisfying that (1) both
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η1(x) and η2(x) are continuous, (2) |
√
λnbDn,λn | ≤ Mb < ∞ almost everywhere, and (3)
|Rg|
π(A,X) ≤ Mg < ∞ almost everywhere with regular marginal distribution on X, we have
that in probability,
lim
n→∞
R(sign(fDn,λn)) = R∗.
2.6 Variable selection for AOL
As demonstrated in Zhou et al. (2017), variable selection is critical for optimal treatment
regime when the dimension of clinical covariates is moderate or high. In this section, we
apply the variable selection techniques in Zhou et al. (2017) to AOL.
2.6.1 Variable selection for linear AOL
As in Zhou et al. (2017), we apply the elastic-net penalty (Zou and Hastie 2005),
λ1||w||1 + λ2
2
wTw,
where ||w||1 =
∑p
j=1 |wj| is the ℓ1-norm, to replace the ℓ2-norm penalty in (8) for vari-
able selection. The elastic-net penalty selects informative covariates through the ℓ1-norm
penalty, and tends to identify or remove highly correlated variables together, the so-called
grouping property, as the ℓ2-norm penalty does.
The elastic-net penalized linear AOL minimizes
1
n
n∑
i=1
|r˜i|
π(ai,xi)
φ
(
ai · sign(r˜i)
(
wTxi + b
))
+ λ1||w||1 + λ2
2
wTw,
where λ1(> 0) and λ2(≥ 0) are regularization parameters. We use projected scaled sub-
gradient (PSS) algorithms (Schmidt 2010), which are extensions of L-BFGS to the case of
optimizing a smooth function with an ℓ1-norm penalty. The obtained decision function is
fˆ(x) = wˆTx+ bˆ, and thus the estimated optimal treatment regime is the sign of fˆ(x).
2.6.2 Variable selection for AOL with nonlinear kernels
Similar in Zhou et al. (2017), taking the Gaussian RBF kernel as an example, we define the
covariates-scaled Gaussian RBF kernel,
Kη(x,z) = exp

− p∑
j=1
ηj(xj − zj)2

 ,
where η = (η1, · · · , ηp)T ≥ 0. The covariate xj is scaled by √ηj . Setting ηj = 0 is
equivalent to discarding the j’th covariate. The hyperparameter σ in the original Gaussian
RBF kernel is discarded as it is absorbed to the scaling factors. We seek (vˆ, bˆ, ηˆ) to minimize
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the following optimization problem:
min
v,b,η
1
n
n∑
i=1
|r˜i|
π(ai,xi)
φ
(
ai · sign(r˜i)
( n∑
j=1
vjKη(xi,xj) + b
))
+λ1||η||1 + λ2
2
n∑
i,j=1
vivjKη(xi,xj), (18)
subject to η ≥ 0,
where λ1(> 0) and λ2(> 0) are regularization parameters. There are n+ p+1 variables for
the optimization problem. It has an ℓ1-norm penalty on scaling factors. It could yield zero
solutions for some of the η due to the singularity at η = 0, and hence performs variable
selection. Note that the optimization problem (18) is not convex any more, even if the loss
function is convex. We apply L-BFGS-B algorithm (Byrd et al. 1995; Morales and Nocedal
2011), an extension of L-BFGS to handle simple box constraints on variables, to solve (18).
Then the obtained decision function is fˆ(x) =
∑n
i=1 vˆiKηˆ(x,xi) + bˆ.
3 Simulation studies
We carried out extensive simulations to investigate empirical performance of the proposed
AOL methods.
We first evaluated performance of different residuals in the framework of AOL. In the
simulations, p-dimensional vectors of clinical covariates x1, · · · , xp were generated from
independent uniform random variables U(−1, 1). The response R was normally distributed
with mean Q0(x, a) and standard deviation 1. We considered two scenarios with linear
treatment regimes:
(1) Q0(x, a) = (0.5 + 0.5x1 + 0.8x2 + 0.3x3 − 0.5x4 + 0.7x5) + a(0.2− 0.6x1 − 0.8x2);
(2) Q0(x, a) = exp [(0.5 + 0.5x1 + 0.8x2 + 0.3x3 − 0.5x4 + 0.7x5) + a(0.2 − 0.6x1 − 0.8x2)].
We evaluated three types of residuals, as discussed in Section 2.4, with respect to the
following g(x)’s:
• g˜(x) = E
(
π(−A,X)
π(A,X) R
∣∣X = x) = π(−1,x)µ+1(x) + π(+1,x)µ−1(x);
• g1(x) = E
(
R
2π(A,X)
∣∣X = x) = 12µ+1(x) + 12µ−1(x);
• g2(x) = E (R|X = x) = π(+1,x)µ+1(x) + π(−1,x)µ−1(x).
g˜(x) is used in the proposed AOL. However, g1(x) in Zhou et al. (2017) and g2(x) in
Liu et al. (2016) also can be applied in AOL to replace g˜(x). In a randomized clinical trial
with usual equal allocation ratio 1:1, i.e. π(+1,x) = π(−1,x) = 0.5, these g(x)’s are the
same. To compare performance of these residuals, we considered unequal allocation ratios
(1) 3:1, i.e., π(+1,x) = 3π(−1,x) and (2) 1:3, i.e., 3π(+1,x) = π(−1,x).
The sample sizes were n = 100 and n = 400 for each scenario. We repeated the
simulation 500 times. Parameters were tuned through 10-fold cross-validation. A large
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Table 1: Mean (std) of empirical value functions evaluated on independent test data for
AOL with three types of residuals in two simulation scenarios with 5 covariates. The best
value function for each scenario and sample size combination is in bold.
allocation ratio = 3:1 allocation ratio = 1:3
n = 100 n = 400 n = 100 n = 400
Scenario 1 (Optimal value 1.001)
g˜(x) 0.940 (0.076) 0.986 (0.018) 0.954 (0.042) 0.974 (0.023)
g1(x) 0.927 (0.087) 0.985 (0.022) 0.945 (0.050) 0.974 (0.022)
g2(x) 0.894 (0.101) 0.978 (0.026) 0.919 (0.066) 0.970 (0.022)
Scenario 2 (Optimal value 3.659)
g˜(x) 3.375 (0.331) 3.451 (0.269) 3.626 (0.034) 3.655 (0.013)
g1(x) 3.363 (0.336) 3.447 (0.282) 3.615 (0.052) 3.650 (0.015)
g2(x) 3.314 (0.347) 3.430 (0.281) 3.584 (0.072) 3.631 (0.021)
independent test set with 10,000 subjects was used to evaluate performance. The evaluation
criterion was the value function of the estimated regime on the test set.
For simplicity, we run the first set of simulations using only linear AOL on low dimen-
sional data (p = 5). g˜(x), g1(x) and g2(x) are obtained by the underlying true distributions
of the data, instead of estimating them from the observed data, to eliminate impacts of
regression estimates on evaluation.
The simulation results on low dimensional data (p = 5) are presented in Table 1.
From the table, the residuals from g˜(x) yielded the best performance for each combination
of scenario, allocation ratio and sample size, especially when the sample size is small.
The simulation results confirm finite sample performance of our proposed counterfactual
residual.
We then compared performance of AOL with other existing methods on usual equal
allocation ratio data. The treatment A ∈ A = {−1, 1} was independent of X with
π(+1,X) = π(−1,X) = 0.5. The covariate X and the outcome R were generated as
previously. We considered two additional scenarios with non-linear treatment regimes:
(3) Q0(x, a) = (0.5 + 0.6x1 + 0.8x2 + 0.3x3 − 0.5x4 + 0.7x5) + a(0.6− x21 − x22);
(4) Q0(x, a) = exp
[
(0.5 + 0.6x1 + 0.8x2 + 0.3x3 − 0.5x4 + 0.7x5) + a(0.6 − x21 − x22)
]
;
We run simulations for two different dimensions of covariates: low dimensional data
(p = 5) and moderate dimensional data (p = 25). On low dimensional data (p = 5),
we compared empirical performances of the following seven methods: (1) ℓ1-PLS pro-
posed by Qian and Murphy (2011); (2) Q-learning using random forests as described in
Taylor et al. (2015) (Q-RF); (3) Doubly robust augmented inverse probability weighted
estimator (AIPWE) with CART proposed by Zhang et al. (2012a) (AIPWE-CART); (4)
RWL proposed in Zhou et al. (2017) using the linear kernel (RWL-Linear); (5) RWL using
the Gaussian RBF kernel (RWL-Gaussian); (6) the proposed AOL using the linear kernel
(AOL-Linear); (7) the proposed AOL using the Gaussian RBF kernel (AOL-Gaussian).
When the dimension was moderate (p = 25), RWL methods were replaced with their vari-
able selection counterparts (RWL-VS-Linear and RWL-VS-Gaussian) (Zhou et al. 2017),
and similarly AOL methods were replaced with AOL-VS-Linear and AOL-VS-Gaussian.
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Table 2: Mean (std) of empirical value functions evaluated on independent test data for
4 simulation scenarios with 5 covariates. The best value function for each scenario and
sample size combination is in bold.
n = 100 n = 400 n = 100 n = 400
Scenario 1 Scenario 2
(Optimal value 1.001) (Optimal value 3.659)
ℓ1-PLS 0.974 (0.021) 0.993 (0.006) 3.537 (0.069) 3.549 (0.041)
Q-RF 0.889 (0.053) 0.952 (0.014) 3.459 (0.137) 3.588 (0.023)
AIPWE-CART 0.855 (0.078) 0.917 (0.034) 3.307 (0.211) 3.503 (0.061)
RWL-Linear 0.930 (0.068) 0.978 (0.018) 3.565 (0.109) 3.640 (0.027)
RWL-Gaussian 0.909 (0.077) 0.973 (0.023) 3.516 (0.126) 3.621 (0.042)
AOL-Linear 0.946 (0.051) 0.985 (0.014) 3.546 (0.125) 3.620 (0.030)
AOL-Gaussian 0.907 (0.082) 0.977 (0.023) 3.517 (0.121) 3.621 (0.037)
Scenario 3 Scenario 4
(Optimal value 0.848) (Optimal value 3.237)
Q-RF 0.619 (0.053) 0.730 (0.028) 2.898 (0.151) 3.127 (0.039)
AIPWE-CART 0.620 (0.086) 0.740 (0.047) 2.909 (0.171) 3.118 (0.056)
RWL-Gaussian 0.638 (0.070) 0.763 (0.041) 2.894 (0.130) 3.125 (0.061)
AOL-Gaussian 0.650 (0.070) 0.784 (0.041) 2.918 (0.135) 3.152 (0.054)
ℓ1-PLS is a parametric regression-based method. In the simulation studies, ℓ1-PLS
estimated the conditional outcomes E(R|X, A) by a linear model on (1,X, A,XA), and
used the LASSO penalty for variable selection. The obtained regime was the treatment
arm in which the conditional mean outcome is larger. Q-RF is a nonparametric regression-
based method. The conditional outcomes E(R|X, A) were approximated using (X, A) as
input covariates in the random forests. The number of trees was set to 1000 as suggested
in Taylor et al. (2015). For AIPWE-CART, we first obtained the AIPWE version of the
contrast function through linear regression, and then we let the propensity score be 0.5 and
searched the optimal treatment regime using a CART. The residuals in RWL and AOL were
the same, and they were estimated by a linear regression model on X. It was different with
the previous simulation. We pretended that we do not know the underlying distribution of
the data, and the residuals were estimated purely based on the simulated data. There are
tuning parameters for ℓ1-PLS, RWL and AOL methods. Parameters were tuned through
10-fold cross-validation.
Again, the sample sizes were n = 100 and n = 400 for each scenario. We repeated
the simulation 500 times. A large independent test set with 10,000 subjects was used to
evaluate performance.
The simulation results on the low dimensional data (p = 5) are presented in Table 2. For
Scenario 1, the optimal regime d∗(x) is 1 if 0.6x1+0.8x2 < 0.2, and −1 otherwise. Both the
decision boundary and the conditional outcome were linear. Thus ℓ1-PLS performed very
well since its model was correctly specified. RWL and AOL methods performed similarly,
and they were close to ℓ1-PLS especially when the sample size was large. Q-RF and AIPWE-
CART, as tree-based methods, were not comparable with other methods, perhaps trees do
not work well to detect linear boundary. For Scenario 2, the optimal treatment regime
was the same as the one in Scenario 1. Although the boundary was linear, both the
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conditional outcome and the contrast function were non-linear. ℓ1-PLS did not yield the
best performance due to model mis-specification. Instead RWL-Linear showed the best
performance. AOL-Linear was slightly worse than RWL-Linear. We used a linear model to
estimate residuals. In this scenario, the linear model for residuals was mis-specified. RWL
is robust to outliers on the residuals (Zhou et al. 2017). As discussed in Section 2.4, the
robustness to outliers is the only nice property that AOL does not inherit from RWL due to
unbounded convex loss function. This is perhaps the reason why AOL-Linear was slightly
worse than RWL. Both RWL-Gaussian and AOL-Gaussian were similarly performed. For
Scenarios 3 and 4 , the decision boundaries were both nonlinear. We show results for Q-
RF, AIPWE-CART, RWL-Gaussian, and AOL-Gaussian since the other three methods,
ℓ1-PLS, RWL-Linear and AOL-Linear, can only detect linear regimes. In Scenario 3, the
model to estimating residuals was correctly specified, while in Scenario 4, this model was
mis-specified. For both scenarios, AOL-Gaussian yielded the best performance, and was
slightly better than RWL-Gaussian. The non-convex optimization with RWL-Gaussian
has a complicated objective function with many local minima or stationary points. It is
very challenging to find a global minimum. The convex AOL-Gaussian does not have such
problem, and hence received better performance than RWL-Gaussian. We also compared
running times of RWL and AOL methods. As shown in Table 5 in Appendix C, AOL is
about 5-10 times faster than RWL. The convex optimization is much more computationally
efficient than non-convex optimization.
We moved to moderate dimension cases (p = 25). The simulation results are shown
in Table 3. In Scenario 1, ℓ1-PLS outperformed other methods because of correct model
specification. When the sample size was large, RWL and AOL methods were all close to
ℓ1-PLS. In Scenario 2, RWL-VS-Linear presented the best performance, and were slightly
better than AOL-VS-Linear. We think the reason is that RWL methods are robust on
mis-specified regression models for estimating residuals. In Scenarios 3 and 4, our proposed
AOL-VS-Gaussian ranked the first, and was slightly better than RWL-VS-Gaussian. Even
though both RWL-VS-Gaussian and AOL-VS-Gaussian involve non-convex optimization,
the objective function of AOL-VS-Gaussian is simpler, and is perhaps easier to find a global
minimum than RWL-VS-Gaussian. We also compared the computational costs of RWL and
AOL, as shown in Table 6 in Appendix C. The cost of AOL was again about 5-10 times
cheaper than that of RWL.
4 Data analysis
We applied the proposed methods to analyze the Nefazodone-CBASP clinical trial data
(Keller et al. 2000). The Nefazodone-CBASP trial randomly assigned patients with non-
psychotic chronic major depressive disorder (MDD) in a 1:1:1 allocation ratio to either
Nefazodone (NFZ), cognitive behavioral-analysis system of psychotherapy (CBASP), or
the combination of Nefazodone and CBASP (COMB). The outcome was the score on the
24-item Hamilton Rating Scale for Depression (HRSD). Lower HRSD is better. We used
50 pre-treatment covariates as in Zhao et al. (2012), and excluded patients with missing
covariate values. The data used here consisted of 647 patients, with 216, 220, and 211
patients in three treatment arms.
We performed pairwise comparisons between any two treatment arms. we compared the
performance of AOL-VS-Linear and AOL-VS-Gaussian with l1-PLS, Q-RF, AIPWE-CART,
18
Table 3: Mean (std) of empirical value functions evaluated on independent test data for
4 simulation scenarios with 25 covariates. The best value function for each scenario and
sample size combination is in bold.
n = 100 n = 400 n = 100 n = 400
Scenario 1 Scenario 2
(Optimal value 1.001) (Optimal value 3.659)
ℓ1-PLS 0.960 (0.036) 0.992 (0.007) 3.423 (0.057) 3.531 (0.036)
Q-RF 0.785 (0.081) 0.926 (0.027) 3.070 (0.375) 3.529 (0.047)
AIPWE-CART 0.794 (0.108) 0.904 (0.038) 3.307 (0.211) 3.503 (0.061)
RWL-VS-Linear 0.869 (0.085) 0.973 (0.020) 3.450 (0.177) 3.632 (0.033)
RWL-VS-Gaussian 0.846 (0.110) 0.963 (0.038) 3.399 (0.234) 3.611 (0.049)
AOL-VS-Linear 0.878 (0.082) 0.976 (0.018) 3.434 (0.153) 3.591 (0.044)
AOL-VS-Gaussian 0.861 (0.106) 0.975 (0.039) 3.421 (0.209) 3.616 (0.037)
Scenario 3 Scenario 4
(Optimal value 0.848) (Optimal value 3.237)
Q-RF 0.541 (0.041) 0.646 (0.038) 2.678 (0.185) 3.006 (0.074)
AIPWE-CART 0.542 (0.062) 0.705 (0.068) 2.724 (0.198) 3.094 (0.066)
RWL-VS-Gaussian 0.559 (0.067) 0.766 (0.061) 2.716 (0.205) 3.166 (0.057)
AOL-VS-Gaussian 0.560 (0.067) 0.774 (0.070) 2.735 (0.209) 3.168 (0.078)
RWL-VS-Linear and RWL-VS-Gaussian, as in the simulation studies. The outcomes used
in the analyses were opposites of HRSD scores. We used a nested 10-fold cross-validation
procedure for an unbiased comparison (Ambroise and McLachlan 2002). Specifically, the
data were randomly partitioned into 10 roughly equal-sized parts. We used nine parts as
training data to predict optimal treatments for patients in the part left out. The parameter
tuning was based on inner 10-fold cross-validation on the training data. We repeated the
procedure 10 times, and obtained the predicted treatment for each patient. We then com-
puted the estimated value function as Pn[RI(A = Pred)/πA(X)]/Pn[I(A = Pred)/πA(X)],
where Pn denotes the empirical average over the data and Pred is the predicted treatment
in the cross validation procedure. To obtain reliable estimates, we repeated the nested
cross-validation procedure 100 times with different fold partitions.
The analysis results are presented in Table 4. For comparison between NFZ and CBASP,
RWL-VS-Linear and AOL-VS-Linear performed better than other methods. For compar-
isons between NFZ and COMB and between CBASP and COMB, all methods produced
similar performance. AOL-VS-Linear was among the top two methods for all comparisons.
As shown in Table 7 in Appendix C, AOL was at least 10 times faster than RWL.
5 Discussion
In this article, we have proposed augmented outcome-weighted learning (AOL) to estimate
optimal treatment regimes. As a close relative of residual weighted learning (RWL), AOL
possesses almost all nice properties of RWL. AOL utilizes a convex loss function to guar-
antee a global solution. By contrast, the nice theoretical properties, for example, universal
consistency, of RWL rely on a global solution, but the non-convex optimization associated
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Table 4: Mean score (standard deviation) on HRSD from the cross-validation procedure
using different methods. Lower HRSD score is better. The two best scores for each com-
parison is in bold.
NFZ vs CBASP NFZ vs COMB CBASP vs COMB
ℓ1-PLS 16.30 (0.39) 11.20 (0.16) 10.95 (0.09)
Q-RF 16.27 (0.44) 11.05 (0.18) 10.93 (0.09)
AIPWE 16.45 (0.41) 10.97 (0.15) 10.96 (0.14)
RWL-VS-Linear 15.45 (0.37) 11.09 (0.29) 10.88 (0.05)
RWL-VS-Gaussian 16.29 (0.44) 11.33 (0.25) 11.07 (0.28)
AOL-VS-Linear 15.77 (0.37) 11.03 (0.18) 10.90 (0.06)
AOL-VS-Gaussian 16.32 (0.36) 11.21 (0.23) 11.02 (0.16)
with RWL cannot guarantee the global optimization. Furthermore, the convex optimization
associated with AOL make it computationally efficient. In the simulation studies and data
analysis, AOL is at least 5-10 times faster than RWL.
There are two main approaches to estimating optimal treatment regimes. Regression-
based approaches posit regression models for either conditional mean outcomes, µ+1(x)
and µ−1(x), or the contrast function, δ(x) = µ+1(x)−µ−1(x), then the optimal treatment
regime is estimated by setting δ(x) = 0. Classification-based approaches directly estimate
the optimal regime δ(x) = 0 in a semiparametric or nonparametric model. Compared
with regression-based approaches, classification-based approaches are more robust to model
misspecification. For example, in Figure 1, the optimal treatment regime δ(x) = 0 is almost
linear, but the contrast function δ(x) is a complicated non-linear function. We may use
the linear AOL to estimate the regime. However, any regression-based approach with
a linear model would be misspecified. Another example is Scenario 2 in the simulation
studies, where the optimal regime is linear, but neither the conditional mean outcome nor
the contrast function is linear. The linear AOL yielded better performance than ℓ1-PLS,
although both methods posit a linear model.
AOL uses a different form of residuals, as compared to RWL. The residuals are esti-
mated with respect to a counterfactual average outcome where all subjects would receive
the opposite treatments to what they have actually received. Apparently, both AOL and
RWL can apply with any form of residuals. In this article, we focus on the randomized
clinical trial data where π(a,x) is known. According to the theory in Section 2.5, for a
randomized clinical trial, AOL with any form of residuals is universally consistent. That
is, it would eventually yield the Bayes regime when the sample size approaches infinity.
When the sample size is finite, the simulations in Section 3 confirm the better performance
of the counterfactual residual over others. The counterfactual residual is derived from a
doubly robust AIPWE. The double robustness is quite useful for the observational study.
In Appendix D, we develop the double robustness on universal consistency, i.e., the esti-
mated regime of AOL is universal consistent if either µˆa(x) or πˆ(a,x) is consistent on the
observational data. We pave the way in theory for AOL in observational studies. It is of
great interest to apply AOL in observational studies in our future work.
In this article, the outcome R is continuous. Zhou et al. (2017) proposed RWL as a gen-
eral framework to deal with continuous, binary, count and rate outcomes. Similarly, AOL
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can handle all these types of outcomes by calculating residuals from a weighted regression
model. The only difference is that the weights of AOL are π(−A,X)π(A,X) , while
1
2π(A,X) for RWL.
Variable selection is critical for optimal treatment regimes (Zhou et al. 2017). Similar
with RWL, we have provided variable selection algorithms for both linear and Gaussian
RBF kernels. The variable selection with the linear kernel is an important extension of
AOL. It seeks the optimal treatment regime semiparametrically, which is suitable for high
dimensional data. Unlike the linear kernel, the variable selection with the Gaussian RBF
kernel involves computationally intensive non-convex optimization, which cannot guaran-
tee a global solution. A convex extension is still needed for our future investigation. Per-
haps we may apply with the Gaussian RBF kernel a similar adaptive metric selection in
Zhou and Kosorok (2017).
APPENDIX
We investigate loss functions in Appendix A. The proofs of theorems in the main paper are
given in Appendix B. We present additional simulation results in Appendix C. The doubly
robustness of AOL on observational data is proved in Appendix D.
APPENDIX A. Loss functions
Example 1 (hinge loss). Consider the loss function φ(α) = (1− α)+. This is the surrogate
loss function used in Zhao et al. (2012) and Liu et al. (2016). Qη1,η2(α) is piecewise-linear.
For η1 = 0, any α ≤ −1 makes Qη1,η2(α) vanish. The same holds for α ≥ 1 for η2 = 0. For
η1, η2 ∈ (0,∞), any minima lie in [−1, 1]. Since Qη1,η2(α) is linear on [−1, 1], the minimum
must be attained at 1 for η1 > η2, −1 for η1 < η2, and anywhere in [−1, 1] for η1 = η2.
We have argued that α∗ = sign(η1 − η2). It is easy to verify that H(η1, η2) = 2min(η1, η2).
Similar argument gives H−(η1, η2) = η1 + η2. H
−(η1, η2) is strictly greater than H(η1, η2)
when η1 6= η2, so the hinge loss is Fisher consistent. Since Hη1,η2 = 2min(η1, η2), we have
∆Qη1,η2(0) = |η1 − η2|. From Theorem 2.2, ∆R(f) ≤ ∆Rφ,g(f).
Example 2 (squared hinge loss). Consider the loss function φ(α) = [(1 − α)+]2. This
function is convex, differentiable, and decreasing at zero, and thus is Fisher consistent. If
η1 = 0, any α ≤ −1 makes Qη1,η2(α) vanish. Similarly, any α ≥ 1 makes the conditional
φ-risk vanish when η2 = 0. For η1, η2 ∈ (0,∞), Qη1,η2(α) is strictly convex with a unique
minimum, and solving for it yields α∗ = (η1 − η2)/(η1 + η2). Simple calculation gives that
Hη1,η2 is 0 when η1 = η2 = 0, and otherwise 4η1η2/(η1 + η2). Then for either case, we have
(η1 − η2)2 = (η1+ η2)∆Qη1,η2(0). If we further assume that E
(
|Rg|
π(A,X)
)
is bounded by Mg,
by Theorem 2.3,
∆R(f) ≤√Mg(∆Rφ,g(f))1/2.
Example 3 (least squares loss). Now consider the loss function φ(α) = (1 − α)2. From
Theorem 2.1, it is Fisher consistent. Simple algebraic manipulations show that Hη1,η2 and
∆Qη1,η2(0) are the same as those in the previous example. Hence the bound in the previous
example also applies to the least squares loss.
Example 4 (Huberized hinge loss). If η1 = 0, any α ≤ −1 makes Qη1,η2(α) vanish.
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Similarly, when η2 = 0 any α ≥ 1 makes the conditional φ-risk vanish. For η1 > 0 and
η2 > 0, Qη1,η2(α) is strictly convex with a unique minimum. Solving by differentiation, the
minimum is obtained at α∗ = (η1−η2)/(η1+η2). Then we haveHη1,η2 is 0 when η1 = η2 = 0,
and otherwise η1η2/(η1+η2). Then for either case, we have (η1−η2)2 = 4(η1+η2)∆Qη1,η2(0).
If we further assume that E
(
|Rg|
π(A,X)
)
is bounded by Mg, by Theorem 2.3,
∆R(f) ≤ 2√Mg(∆Rφ,g(f))1/2.
Example 5 (logistic loss). We consider the loss function φ(α) = log(1+ exp(−α)). This
loss function is convex, differentiable, and decreasing at zero, and thus is Fisher consistent.
We first consider the case that η1 6= 0 and η2 6= 0. Simple calculation gives that Qη1,η2(α)
attains its minimum at α∗ = log(η1/η2), and
∆Qη1,η2(0) = η1 log
(
2η1
η1 + η2
)
+ η2 log
(
2η2
η1 + η2
)
.
We fix η2, and see ∆Qη1,η2(0) as a function of η1. Using Taylor expansion around η1 = η2,
we have
∆Qη1,η2(0) =
1
2
η2
η˜1(η˜1 + η2)
(η1 − η2)2,
where η˜1 is between η1 and η2. Similarly, fix η1, and again use Taylor expansion around
η2 = η1,
∆Qη1,η2(0) =
1
2
η1
η˜2(η1 + η˜2)
(η1 − η2)2,
where η˜2 is between η1 and η2. By summing these two equations, we obtain
2∆Qη1,η2(0) =
1
2
η2
η˜1(η˜1 + η2)
(η1 − η2)2 + 1
2
η1
η˜2(η1 + η˜2)
(η1 − η2)2
≥ 1
2
η2
2(η1 + η2)2
(η1 − η2)2 + 1
2
η1
2(η1 + η2)2
(η1 − η2)2
=
(η1 − η2)2
4(η1 + η2)
.
So, we have
(η1 − η2)2 ≤ 8(η1 + η2)∆Qη1,η2(0).
It is easy to verify that when η1 = 0 or η2 = 0, the above bound holds. If we further assume
that E
(
|Rg|
π(A,X)
)
is bounded by Mg, by Theorem 2.3,
∆R(f) ≤√8Mg(∆Rφ,g(f))1/2.
Example 6 (DWD loss). The DWD loss is convex, differentiable and decreasing at zero.
Hence this loss function is Fisher consistent. When η1, η2 ∈ (0,∞), consider three cases,
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(1) η1 > η2; (2) η2 > η1; (3) η1 = η2. Simple differentiation yields that the minimizer is
α∗ =


√
η1
η2
if η1 > η2 > 0,
any point ∈ [−1, 1] if η1 = η2 > 0,
−
√
η2
η1
if η2 > η1 > 0.
When η1 > η2 > 0, we have Hη1,η2 = 2η2 + 2
√
η1η2. Then,
∆Qη1,η2(0) = 2η1 − 2
√
η1η2 =
2
√
η1√
η1 +
√
η2
(η1 − η2) ≥ |η1 − η2|. (19)
Similarly, when η2 > η1 > 0, (19) holds. It is easy to verify that when η1 = η2 or at least
one of η1 and η2 is zero, the inequality (19) holds too. By Theorem 2.2, ∆R(f) ≤ ∆Rφ,g(f).
Example 7 (exponential loss). Consider the loss function φ(α) = exp(−α). Again, this
function is convex, differentiable, and decreasing at zero, and thus is Fisher consistent.
For η1, η2 ∈ (0,∞), solving for the stationary point yields the unique minimizer α∗ =
argminα∈RQη1,η2(α) =
1
2 log (η1/η2). Then Hη1,η2 = 2
√
η1η2, and ∆Qη1,η2(0) = (
√
η1 −√
η2)
2. Note that (
√
η1 +
√
η2)
2 ≤ 2(η1 + η2), then we have,
(η1 − η2)2 ≤ 2(η1 + η2)∆Qη1,η2(0).
It is easy to verify that when η1 = 0 or η2 = 0, the above inequality holds. With an
additional assumption that E
(
|Rg|
π(A,X)
)
is bounded by Mg, from Theorem 2.3,
∆R(f) ≤√2Mg(∆Rφ,g(f))1/2.
APPENDIX B. Proofs
Proof of Theorem 2.1
Proof. Recall that Qη1,η2(α) = η1φ(α) + η2φ(−α). It is easy to check that Qη1,η2 is convex.
We consider the ‘if ’ part of the proof first. Suppose that φ is differentiable at 0 and has
φ′(0) < 0. Assume without loss of generality that η1 > η2. We need to prove that Qη1,η2(α)
is not minimized by any α ∈ (−∞, 0], i.e. α∗ > 0. Because φ is convex, it follows that for
any h > 0
φ(0) + hφ′(0) ≤ φ(h)
φ(0) − hφ′(0) ≤ φ(−h).
Therefore, noting that Qη1,η2(0) = φ(0)(η1 + η2), it is derived that
Qη1,η2(−h)−Qη1,η2(0) = η1 (φ(−h)− φ(0)) + η2 (φ(h)− φ(0))
≥ −(η1 − η2)φ′(0)h,
that is, given φ′(0) < 0, for any h > 0, Qη1,η2(−h)−Qη1,η2(0) > 0. Consequently, α∗ ≥ 0 be-
cause it is a minimum. To prove the strict inequality, note that given that φ is differentiable
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at zero, by definition, for any ǫ > 0 there exists a δ(ǫ) > 0 such that
δ−1 (φ(δ) − φ(0)) ≤ φ′(0) + ǫ
δ−1 (φ(0) − φ(−δ)) ≥ φ′(0)− ǫ.
This implies that
Qη1,η2(δ) −Qη1,η2(0) = η1 (φ(δ) − φ(0)) + η2 (φ(−δ) − φ(0))
≤ η1δ
(
φ′(0) + ǫ
)
+ η2δ
(
ǫ− φ′(0))
= δ
(
φ′(0)(η1 − η2) + ǫ(η1 + η2)
)
,
thus, making ǫ small enough, φ′(0)(η1 − η2) + ǫ(η1 + η2) < 0. It follows that α∗ > 0.
We proceed now with the ‘only if ’ part of the proof. Suppose φ is Fisher consistent.
Note that if α∗ minimizes Qη1,η2(α), it follows that Qη1,η2(α
∗)−Qη1,η2(0) < 0 when η1 6= η2.
Note that
Qη1,η2(α
∗)−Qη1,η2(0) = η1(φ(α∗)− φ(0)) + η2(φ(−α∗)− φ(0)) (20)
We need to prove that φ′(0) < 0. Let [a, b] be the subderivative of φ at zero. By
definition, if h > 0,
φ(h)− φ(0) ≥ bh
φ(−h)− φ(0) ≥ −ah. (21)
First we are going to prove that b < 0. Suppose by contradiction that b ≥ 0. If η1 > η2
then α∗ > 0 from the definition of Fisher consistency. By (21), φ(α∗) ≥ φ(0), and replacing
in (20), it is necessary that φ(−α∗) < φ(0) in order to keep the optimality property of α∗.
By (21) again, we have that 0 < a ≤ b. Consequently, by replacing (21) with h = α∗ into
(20),
Qη1,η2(α
∗)−Qη1,η2(0) ≥ α∗ (b(η1 − η2)− η2(a− b)) > 0,
which contradicts that α∗ is the minimum. Therefore, it is concluded that b < 0.
It remains to prove that a = b. To do so, suppose by contradiction that a < b < 0.
This implies that it is possible to have a distribution such that η1 > η2 and η1b > η2a, and
therefore α∗ > 0. By replacing (21) with h = α∗ into (20) again,
Qη1,η2(α
∗)−Qη1,η2(0) ≥ α∗ (η1b− η2a) > 0,
which contradicts the fact that α∗ minimizes Qη1,η2 . It follows that φ is differentiable at
zero and φ′(0) < 0.
Proof of Theorem 2.2
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Proof.
E
(
R
π(A,X)
I(A 6= sign(f(X)))
∣∣∣X)− E( R
π(A,X)
I(A 6= d∗(X))
∣∣∣X)
=
(
E(R|X, A = 1)− E(R|X, A = −1)
)(
I
(
d∗(X) = 1
)− I(sign(f(X)) = 1))
≤
∣∣∣η1(X)− η2(X)∣∣∣I(sign(f(X))(η1(X)− η2(X)) < 0).
Then taking expectation on both sides we have,
∆R(f) ≤ E
(∣∣η1(X)− η2(X)∣∣I(sign(f(X))(η1(X)− η2(X)) < 0))
≤
(
E
(∣∣η1(X) − η2(X)∣∣sI(sign(f(X))(η1(X)− η2(X)) < 0)))1/s
≤ C
(
E
(
∆Qη1(X),η2(X)(0)I
(
sign(f(X))
(
η1(X)− η2(X)
)
< 0
)))1/s
.
The second inequality follows from the Jensen’s inequality. By the conditions of φ, φ is
Fisher consistent. Let α∗ minimizes Qη1,η2(α). When sign(f)·(η1−η2) < 0, by the definition
of Fisher consistent, 0 is between f and α∗. The convexity of φ, and hence of Qη1,η2 , implies
that
Qη1,η2(0) ≤ max(Qη1,η2(f), Qη1,η2(α∗)) = Qη1,η2(f).
So we have,
∆R(f) ≤ C
(
E
(
∆Qη1(X),η2(X)(f)I
(
sign(f(X))
(
η1(X)− η2(X)
)
< 0
)))1/s
≤ C(∆Rφ,g(f))1/s.
Proof of Theorem 2.3
Proof. Following the similar arguments in the proof of Theorem 2.2, we have
∆R(f) = E
(∣∣η1(X)− η2(X)∣∣I(sign(f(X))(η1(X)− η2(X)) < 0))
≤
(
E
(∣∣η1(X)− η2(X)∣∣s/2I(sign(f(X))(η1(X)− η2(X)) < 0)))2/s
≤
(
E
(
h(η1(X) + η2(X))
1/2∆Qη1(X),η2(X)(0)
1/2
I
(
sign(f(X))
(
η1(X)− η2(X)
)
< 0
)))2/s
≤
(
E
(
h(η1(X) + η2(X))
1/2∆Qη1(X),η2(X)(f(X))
1/2
))2/s
≤
(
E
(
h(η1(X) + η2(X))
)
E
(
∆Qη1(X),η2(X)(f(X))
))1/s
≤
(
h(E(η1(X) + η2(X)))
)1/s
(∆Rφ,g(f))1/s.
The second and sixth inequalities follows from the Jensen’s inequality, and the fifth follows
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Cauchy-Schwarz inequality. Notice that
E
( |Rg|
π(A,X)
∣∣∣X) = E(|Rg||X, A = 1) + E(|Rg||X, A = −1)
= E(R+g +R
−
g |X, A = 1) + E(R+g +R−g |X, A = −1)
= η1(X) + η2(X).
So E
(
|Rg|
π(A,X)
)
= E(η1(X) + η2(X)). The desired result follows through the monotonicity
of h.
Proof of Theorem 2.4
Proof. Let L(h, b) = |Rg|φ(Asign(Rg)(h(X) + b))/π(A,X). For simplicity, we denote
fDn,λn , hDn,λn and bDn,λn by fn, hn and bn, respectively. By the definition of hDn,λn
and bDn,λn , we have, for any h ∈ HK and b ∈ R,
Pn(L(hn, bn)) ≤ Pn(L(hn, bn)) + λn
2
||hn||2K ≤ Pn(L(h, b)) +
λn
2
||h||2K ,
where Pn denotes the empirical measure of the observed data. Then, lim supn Pn(L(hn, bn)) ≤
P(L(h, b)) = Rφ,g(h+ b) with probability 1. This implies
lim sup
n
Pn(L(hn, bn)) ≤ inf
h∈HK ,b∈R
Rφ,g(h+ b) ≤ P(L(hn, bn))
with probability 1. It suffices to show Pn(L(hn, bn))− P(L(hn, bn))→ 0 in probability.
We have a bound for |bn|, |
√
λnbn| ≤ Mb, as a condition. We next obtain a bound for
||hn||K . Since Pn(L(hn, bn)) + λn||hn||2K/2 ≤ Pn(L(h, b)) + λn||h||2K/2, for any h ∈ HK
and b ∈ R, we can choose h = 0 and b = 0 to obtain, Pn(L(hn, bn)) + λn||hn||2K/2 ≤
φ(0)Pn(|Rg|/π(A,X)). We thus have,
λn||hn||2K ≤ 2φ(0)Pn(|Rg|/π(A,X)) ≤ 2φ(0)Mg .
Let Mh =
√
2φ(0)Mg . Then the HK norm of
√
λnhn is bounded by Mh.
Note that the class {√λnh : ||
√
λnh||K ≤ Mh} is a Donsker class. So {
√
λn(h + b) :
||√λnh||K ≤Mh, |
√
λnb| ≤Mb} is also P-Donsker.
Consider a function φλn(u) =
√
λnφ(u/
√
λn). φλn(u) is a Lipschitz continuous function
with the same Lipschitz constant as φ(u). Note that
√
λnL(h, b) =
|Rg|
π(A,X)
φλn(A
√
λn · sign(Rg)(h(X) + b)).
Since φλn(u) is Lipschitz continuous and
|Rg|
π(A,X) is bounded, the class {
√
λnL(h, b) : ||
√
λnh||K ≤
Mh, |
√
λnb| ≤Mb} is also P-Donsker. Therefore√
nλn(Pn − P)L(hn, bn) = Op(1).
Consequently, from nλn →∞, Pn(L(hn, bn))− P(L(hn, bn))→ 0 in probability.
Proof of Lemma 2.5
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Proof. Fix any 0 < ǫ < 1. Suppose φ is Lipschitz continuous with Lipschitz constant
C. Let µ be the marginal distribution of X. Since µ is regular and f∗φ,g is measurable,
using Lusin’s theorem in measure theory, we know that f∗φ,g can be approximated by a
continuous function f ′(x) ∈ C(X ) such that µ(f ′(x) 6= f∗φ,g(x)) ≤ ǫ4CMfMg . Since f∗φ,g
is between [−Mf ,Mf ], we may limit f ′(x) ∈ [−Mf ,Mf ] (otherwise, truncate f ′(x) with
upper bound Mf and lower bound −Mf ). Thus
E
( |Rg|
π(A,X)
φ
(
A · sign(Rg)f ′(X)
)∣∣∣X = x)− E( |Rg|
π(A,X)
φ
(
Asign(Rg)f
∗
φ,g(X)
)∣∣∣X = x)
= η1(x)
[
φ(f ′(x))− φ(f∗φ,g(x))
]
+ η2(x)
[
φ(−f ′(x))− φ(−f∗φ,g(x))
]
≤ C(η1(x) + η2(x))|f ′(x)− f∗φ,g(x)|.
The last inequality is due to the fact that φ is Lipschitz continuous. Then, we have,
Rφ,g(f ′)−R∗φ,g = |Rφ,g(f ′)−R∗φ,g|
≤ C
∫ (
η1(x) + η2(x)
)|f ′(x)− f∗φ,g(x)|µ(dx)
= C
∫
E
( |Rg|
π(A,X)
∣∣∣X = x)|f ′(x)− f∗φ,g(x)|I(f ′(x) 6= f∗φ,g(x))µ(dx)
Since
|Rg|
π(A,X) ≤Mg and both f ′(x) and f∗φ,g(x) are between [−Mf ,Mf ], we have
Rφ,g(f ′)−R∗φ,g < ǫ/2.
Since K is universal, there exists a function f ′′ ∈ HK such that ||f ′′ − f ′||∞ < ǫ2CMg .
Similarly,
|Rφ,g(f ′′)−Rφ,g(f ′)|
≤ C
∫ (
η1(x) + η2(x)
)|f ′′(x)− f ′(x)|µ(dx)
= C
∫
E
( |Rg|
π(A,X)
∣∣∣X = x)|f ′′(x)− f ′(x)|µ(dx)
< ǫ/2.
By combining the two inequalities, we have
RT,g(f ′′)−R∗φ,g < ǫ.
Noting that f ′′ ∈ HK and letting ǫ→ 0, we obtain the desired result.
Proof of Proposition 2.7
Proof. When
|Rg|
π(A,X) is bounded, the excess risk is bounded as argued in Section 2.4.2,
∆R(f) ≤ 2
√
Mg(∆Rφ,g(f))1/2. (22)
Next, we obtain a bound for bfDn,λn . We use the notations in the proof of Theorem 2.4.
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We claim that there is a solution (hn, bn) such that hn(xi)+bn ∈ [−1, 1] for some i. Suppose
that there is another solution (h′n, b
′
n) such that |hn(xi) + bn| > 1 for all i. Let D1 = {i :
Aisign(Rg,i) = 1, h
′
n(Xi) + b
′
n < −1} and D2 = {i : Aisign(Rg,i) = −1, h′n(Xi) + b′n > 1}.
Denote
α1 =
∑
i∈D1
|Rg,i|
π(Ai,Xi)
, and α2 =
∑
i∈D2
|44Rg,i|
π(Ai,Xi)
.
We show that α1 = α2. Otherwise, when α1 > α2, let
δ = min
i:h′n(Xi)+b
′
n<−1
|h′n(Xi) + b′n|.
Then set hn = h
′
n and bn = b
′
n+(δ−1). It is easy to check that (hn, bn) is a better solution
than (h′n, b
′
n), which is contradicted with the fact that (h
′
n, b
′
n) is a solution. Similarly, when
α1 < α2, let
δ = min
i:h′n(Xi)+b
′
n>1
|h′n(Xi) + b′n|. (23)
Then set hn = h
′
n and bn = b
′
n− (δ− 1). Thus (hn, bn) is a better solution than (h′n, b′n). It
is a contradiction again. So we have α1 = α2. However, when we set δ as in (23), hn = h
′
n
and bn = b
′
n − (δ − 1). (hn, bn) is a solution and satisfies our claim. Now if a solution
(hn, bn) satisfies our claim for subject i0, we then have,
|bn| ≤ 1 + |hn(Xi0)| ≤ 1 + ||hn||∞.
Note that ||h||∞ ≤ CK ||h||K . We have,
|
√
λnbn| ≤
√
λn + CK
√
λn||hn||K .
As in the proof of Theorem 2.4,
√
λn||hn||K is bounded. Since λn → 0, and CK is bounded,
we have |√λnbn| is bounded too. So by Theorem 2.4,
lim
n→∞
Rφ,g(fDn,λn) = inf
f∈HK+{1}
Rφ,g(f). (24)
By the argument in Appendix A, the optimal function
f∗φ,g(x) =


0 if η1(x) = η2(x) = 0,
η1(x)− η2(x)
η1(x) + η2(x)
otherwise.
Clearly, f∗φ,g is measurable, and |f∗φ,g(x)| ≤ 1. By Lemma 2.5
inf
f∈HK+{1}
Rφ,g(f) = R∗φ,g. (25)
Combining (22), (24) and (25), we have the desired result.
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APPENDIX C. Additional results in the simulation study
and data analysis
In this section, we compared the computational cost of AOL with RWL. In the simulation
studies, the average running times of the first 10 runs of AOL and RWL with tuned param-
eters listed in Table 5 for low dimensional data (p = 5) and listed in Table 5 for moderate
dimensional data (p = 25). AOL is about 5-10 times faster than RWL.
For the real data analysis in Section 4, we averaged the running times in the 10 runs of
the first fold partition of cross-validation with tuned parameters. AOL is at least 10 times
faster than RWL.
APPENDIX D. Double robustness of AOL on observational
data
In the main paper, AOL is mainly applied to randomized clinical trial data. This method
also can be used on observational data. In an observational study, we first estimate π(a,x)
by, for example, πˆ(a,x). Then we need to estimate g˜(x) by
ˆ˜g(x) = πˆ(−1,x)µˆ+1(x) + πˆ(+1,x)µˆ−1(x),
where µˆ+1(x) and µˆ−1(x) are estimators of µ+1(x) and µ−1(x), respectively. g˜(x) also can
be estimated by weighted regression with weights πˆ(−a,x)/πˆ(a,x).
Here we suppress the dependence on observed data Dn for notations πˆ(a,x), µˆ+1(x), and
µˆ−1(x). Suppose that when n approaches infinity, πˆ(a,x)
p→ π˜(a,x), µˆ+1(x) p→ µ˜+1(x),
and µˆ−1(x)
p→ µ˜−1(x). When µˆ+1(x) and µˆ−1(x) are consistent, µ˜+1(x) = µ+1(x) and
µ˜−1(x) = µ−1(x). When πˆ(a,x) is consistent, πˆ(a,x) = π(a,x).
Again, for finite sample observational data Dn, let fDn,λn ∈ HK + {1}, i.e. fDn,λn =
hDn,λn+ bDn,λn , where hDn,λn ∈ HK and bDn,λn ∈ R, be a global minimizer of the following
optimization problem:
min
f=h+b∈HK+{1}
1
n
n∑
i=1
|Rˆ˜g,i|
πˆ(Ai,Xi)
φ
(
Ai · sign(Rˆ˜g,i)f(Xi)
)
+
λn
2
||h||2K , (26)
where Rˆ˜g,i = Ri − ˆ˜g(Xi). Here we suppress φ and g from the notations of fDn,λn , hDn,λn
and bDn,λn .
Note that |r|φ(sign(r)f) is continuous with respect to r. By the law of large numbers
and the continuous mapping theorem,
1
n
n∑
i=1
|Rˆ˜g,i|
πˆ(Ai,Xi)
φ
(
Ai · sign(Rˆ˜g,i)f(Xi)
)
p→ E
( |Rg|
π˜(A,X)
φ
(
A · sign(Rg)f(X)
))
,
where Rg = R− g(X) and g(x) = π˜(−1,x)µ˜+1(x) + π˜(+1,x)µ˜−1(x) in this section. As in
the case of the randomized clinical trial in the main paper, we define the risk function of a
treatment regime d as
R(d) = E
(
R
π(A,X)
I
(
A 6= d(X)
))
.
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Table 5: Running times (in seconds) of AOL and RWL for 4 simulation scenarios on 5-
covariate data.
n = 100 n = 400
AOL RWL AOL RWL
Linear kernel
Scenario 1 0.010 0.046 0.012 0.068
Scenario 2 0.011 0.062 0.013 0.073
Gaussian kernel
Scenario 1 0.040 0.479 0.123 0.731
Scenario 2 0.078 0.657 0.191 1.012
Scenario 3 0.104 0.440 0.098 0.888
Scenario 4 0.099 0.432 0.410 3.557
Table 6: Running times (in seconds) of AOL and RWL with variable selection for 4 simu-
lation scenarios on 25-covariate data.
n = 100 n = 400
AOL RWL AOL RWL
Linear kernel
Scenario 1 0.006 0.042 0.010 0.055
Scenario 2 0.008 0.073 0.012 0.111
Gaussian kernel
Scenario 1 0.298 1.169 5.660 35.651
Scenario 2 0.422 2.045 5.561 23.265
Scenario 3 0.752 2.544 9.487 24.264
Scenario 4 0.365 1.896 11.831 50.391
Table 7: Running times (in seconds) of AOL and RWL with variable selection on the
Nefazodone-CBASP clinical trial data.
NFZ vs CBASP NFZ vs COMB CBASP vs COMB
AOL RWL AOL RWL AOL RWL
Linear kernel 0.008 0.638 0.011 0.373 0.007 0.084
Gaussian kernel 25.334 390.773 21.598 283.986 10.445 96.627
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For observational data, we define the surrogate φ-risk function:
Rφ,g(f) = E
( |Rg|
π˜(A,X)
φ
(
A · sign(Rg)f(X)
))
. (27)
Similarly, the minimal φ-risk as R∗φ,g = inff Rφ,g(f) and f∗φ,g = argminf Rφ,g(f).
The purpose of this section is to investigate the universal consistency of the associated
regime of fDn,λn on observational data. We check the theoretical properties in Section 2.5
for observational data in parallel.
First, let us investigate the conditions for R(sign(f∗φ,g)) = R(d∗). Define
η˜1(x) = E(R
+
g |X = x, A = +1)
π(+1,x)
π˜(+1,x)
+ E(R−g |X = x, A = −1)
π(−1,x)
π˜(−1,x) ,
η˜2(x) = E(R
+
g |X = x, A = −1)
π(−1,x)
π˜(−1,x) + E(R
−
g |X = x, A = +1)
π(+1,x)
π˜(+1,x)
. (28)
The φ-risk can be expressed as
Rφ,g(f) = E
(
η˜1(X)φ
(
f(X)
)
+ η˜2(X)φ
( − f(X))).
The condition in Theorem 2.1, i.e., φ′(0) exists and φ′(0) < 0, only guarantees that f∗φ,g(x)
has the same sign as η˜1(x)− η˜2(x).
When πˆ(a,x) is consistent, it is obvious that η˜1(x)− η˜2(x) = µ+1(x)− µ−1(x). When
µˆ+1(x) and µˆ−1(x) are consistent, we have g(x) = π˜(−1,x)µ+1(x) + π˜(+1,x)µ−1(x), and
η˜1(x)− η˜2(x) = [µ+1(x)− g(x)]π(+1,x)
π˜(+1,x)
− [µ−1(x)− g(x)]π(−1,x)
π˜(−1,x) = µ+1(x)− µ−1(x).
The conditions for R(sign(f∗φ,g)) = R(d∗) are (i) either µˆa(x) or πˆ(a,x) is consistent; and
(ii) φ′(0) exists and φ′(0) < 0.
For the excess risk bound, we can easily verify that Theorem 2.2 holds for observational
data with an additional condition as follows.
Theorem D.1. Assume either µˆa(x) or πˆ(a,x) is consistent, φ is convex, φ
′(0) exists and
φ′(0) < 0. In addition, suppose that there exist constants C > 0 and s ≥ 1 such that
|η˜1 − η˜2|s ≤ Cs∆Qη˜1,η˜2(0),
Then
∆R(f) ≤ C (∆Rφ,g(f))1/s .
Theorem 2.3 can be modified for observational data as follows by noticing that
η˜1(x) + η˜2(x) = E
( |Rg|
π˜(A,X)
∣∣∣X = x) .
Theorem D.2. Assume either µˆa(x) or πˆ(a,x) is consistent, φ is convex, φ
′(0) exists,
and φ′(0) < 0. Suppose E
(
|Rg|
π˜(A,X)
)
≤Mg. In addition, suppose that there exist a constant
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s ≥ 2 and a concave increasing function h : R+ → R+ such that
|η˜1 − η˜2|s ≤ h(η˜1 + η˜2)∆Qη˜1,η˜2(0),
Then
∆R(f) ≤ (h(Mg))1/s (∆Rφ,g(f))1/s .
Thus, all excess risk bounds provided in Section 2.5.2 apply to observational data when
either µˆa(x) or πˆ(a,x) is consistent.
For universal consistency, the following theorem is just the counterpart of Theorem 2.4
on observational data.
Theorem D.3. Suppose φ is a Lipschitz continuous function. Assume that we choose a
sequence λn > 0 such that λn → 0 and nλn → ∞. For any distribution P for (X, A,R)
satisfying
|Rˆ˜g|
πˆ(A,X) ≤ M < ∞ and |
√
λnbDn,λn | ≤ Mb < ∞ almost everywhere, we have that
in probability,
lim
n→∞
Rφ,g(fDn,λn) = inf
f∈HK+{1}
Rφ,g(f).
The proof follows the idea in the proof of Theorem 2.4. We only show a sketch.
Proof. Let Ln(h, b) = |Rˆ˜g|φ(Asign(Rˆ˜g)(h(X)+b))/πˆ(A,X) and L(h, b) = |Rg|φ(Asign(Rg)(h(X)+
b))/π˜(A,X). By the continuous mapping theorem, Ln(h, b)
p→ L(h, b). So PLn(h, b)→PL(h, b).
For any h ∈ HK and b ∈ R, we have
Pn(Ln(hn, bn)) ≤ Pn(Ln(hn, bn)) + λn
2
||hn||2K ≤ Pn(Ln(h, b)) +
λn
2
||h||2K .
Then, lim supn Pn(L(hn, bn)) ≤ P(L(h, b)) = Rφ,g(h+ b) with probability 1. This implies
lim sup
n
Pn(Ln(hn, bn)) ≤ inf
h∈HK ,b∈R
Rφ,g(h+ b) ≤ P(L(hn, bn))
with probability 1. It suffices to show Pn(Ln(hn, bn)) − P(Ln(hn, bn)) → 0 in probability
since PLn(h, b)→PL(h, b).
Similar as in the proof of Theorem 2.4, we derive a bound for hn as
λn||hn||2K ≤ 2φ(0)Pn(|Rg|/π(A,X)) ≤ 2φ(0)M.
Let Mh =
√
2φ(0)M . Then, {√λn(h+ b) : ||
√
λnh||K ≤Mh, |
√
λnb| ≤Mb} is P-Donsker.
Consider a function φλn(u) =
√
λnφ(u/
√
λn). Note that
√
λnLn(h, b) =
|Rˆ˜g|
πˆ(A,X)
φλn(A
√
λn · sign(Rˆ˜g)(h(X) + b)).
Since φλn(u) is Lipschitz continuous and
|Rˆ˜g|
πˆ(A,X) is bounded, the class {
√
λnLn(h, b) :
||√λnh||K ≤Mh, |
√
λnb| ≤Mb} is also P-Donsker. Therefore√
nλn(Pn − P)L(hn, bn) = Op(1).
Consequently, from nλn →∞, Pn(L(hn, bn))− P(L(hn, bn))→ 0 in probability.
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Following the similar arguments in Section 2.5.3, for the Huberized hinge loss, we have
universal consistency of AOL on observational data.
Proposition D.4. Assume either µˆa(x) or πˆ(a,x) is consistent. Let K be a universal
kernel, and HK be the associated RKHS. Let φ be the Huberized hinge loss function. Assume
that we choose a sequence λn > 0 such that λn → 0 and nλn → ∞. For any distribution
P for (X, A,R) satisfying
|Rˆ˜g|
πˆ(A,X) ≤ M < ∞ almost everywhere with regular marginal
distribution on X, we have that in probability,
lim
n→∞
R(sign(fDn,λn)) = R∗.
We may achieve universal consistency for other loss functions as we did in Section 2.5.3.
AOL is doubly robust on universal consistency for observational data.
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